First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study

Taieb, Julien; Prager, Gerald W; Melisi, Davide; Westphalen, C Benedikt; D'Esquermes, Nathalie; Ferreras, Anabel; Carrato, Alfredo; Macarulla, Teresa

doi:10.1136/esmoopen-2019-000587

Treatment of metastatic pancreatic adenocarcinoma (mPAC) relies on chemotherapeutic regimens. We investigated patterns of first-line and second-line treatment choices, their geographical variation between European countries, and alignment with current European recommendations.

Titolo:	First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study
Autori:	Taieb, Julien Prager, Gerald W MELISI, Davide Westphalen, C Benedikt D'Esquermes, Nathalie Ferreras, Anabel Carrato, Alfredo Macarulla, Teresa mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2020
Rivista:	ESMO OPEN
Abstract:	Treatment of metastatic pancreatic adenocarcinoma (mPAC) relies on chemotherapeutic regimens. We investigated patterns of first-line and second-line treatment choices, their geographical variation between European countries, and alignment with current European recommendations.
Handle:	http://hdl.handle.net/11562/1014043
Appare nelle tipologie:	01.01 Articolo in Rivista

File in questo prodotto:

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11562/1014043

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

CATALOGO DEI PRODOTTI DELLA RICERCA

File in questo prodotto: